InvestorsHub Logo
Followers 120
Posts 20661
Boards Moderated 0
Alias Born 06/13/2011

Re: sts66 post# 115488

Wednesday, 10/04/2017 2:37:15 PM

Wednesday, October 04, 2017 2:37:15 PM

Post# of 425915
STS Dr Nina Bailey ..PharmEPA responds

-----------------------------

Thanks for getting in touch. Our product Pharmepa RESTORE is a 90% rTG EPA that is identical to one that was formulated specifically for use in the SeaFood Polyp Prevention trial. ( my highlight )

The lead investigator of that trial was responsible for gaining the Investigation al Medicinal Product Dossier (IMPD) required for the approval of the product in clinical trials by the competent authorities in the EU. The trial product was awarded the IMPD in 2014 and the study I believe is now complete with the result expected to be published next year.

Hope this clarifies things for you

Best wishes

Nina
--
Nina Bailey BSc Hons, MSc, PhD, RNutr
Nutrition Scientist
Registered Nutritionist (UKVRN 6624)

Igennus Healthcare Nutrition - Manufacturers of specialist EPA fatty acid supplements

--------------------------
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News